{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T11:04:25Z","timestamp":1773486265331,"version":"3.50.1"},"reference-count":32,"publisher":"Spandidos Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.3892\/or.2013.2625","type":"journal-article","created":{"date-parts":[[2013,7,18]],"date-time":"2013-07-18T05:36:13Z","timestamp":1374125773000},"page":"1645-1650","source":"Crossref","is-referenced-by-count":44,"title":["Targeting cancer stem cells in glioblastoma multiforme using mTOR inhibitors and the differentiating agent all-trans retinoic acid"],"prefix":"10.3892","volume":"30","author":[{"given":"MARISSA D.","family":"FRIEDMAN","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DHRUVE S.","family":"JEEVAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MICHAEL","family":"TOBIAS","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"RAJ","family":"MURALI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MEENA","family":"JHANWAR-UNIYAL","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2013,7,18]]},"reference":[{"key":"key20180107223334_b1-or-30-04-1645","doi-asserted-by":"crossref","first-page":"4228","DOI":"10.1002\/cncr.26685","article-title":"Improving prognosis of glioblastoma in the 21st century: who has benefited most?","volume":"118","author":"Lawrence","year":"2012","journal-title":"Cancer"},{"key":"key20180107223334_b2-or-30-04-1645","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ccr.2008.02.010","article-title":"Feedback circuit among INK4 tumor suppressors constrains human glioblastoma development","volume":"13","author":"Wiedemeyer","year":"2008","journal-title":"Cancer Cell"},{"key":"key20180107223334_b3-or-30-04-1645","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.2353\/ajpath.2007.070011","article-title":"Genetic pathways to primary and secondary glioblastoma","volume":"170","author":"Ohgaki","year":"2007","journal-title":"Am J Pathol"},{"key":"key20180107223334_b4-or-30-04-1645","doi-asserted-by":"crossref","first-page":"5416","DOI":"10.1038\/onc.2008.239","article-title":"PTEN signaling in brain: neuropathology and tumorigenesis","volume":"27","author":"Endersby","year":"2008","journal-title":"Oncogene"},{"key":"key20180107223334_b5-or-30-04-1645","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1101\/gad.12.23.3675","article-title":"A constitutively active epidermal growth factor receptor cooperates with disruption of G1 cell-cycle arrest pathways to induce glioma-like lesions in mice","volume":"12","author":"Holland","year":"1998","journal-title":"Genes Dev"},{"key":"key20180107223334_b6-or-30-04-1645","doi-asserted-by":"crossref","first-page":"7011","DOI":"10.1158\/0008-5472.CAN-04-1364","article-title":"Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma","volume":"64","author":"Galli","year":"2004","journal-title":"Cancer Res"},{"key":"key20180107223334_b7-or-30-04-1645","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1056\/NEJMra043666","article-title":"Neural stem cells and the origin of gliomas","volume":"353","author":"Sanai","year":"2005","journal-title":"N Engl J Med"},{"key":"key20180107223334_b8-or-30-04-1645","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nature03128","article-title":"Identification of human brain tumour initiating cells","volume":"432","author":"Singh","year":"2004","journal-title":"Nature"},{"key":"key20180107223334_b9-or-30-04-1645","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/glia.10094","article-title":"Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro","volume":"39","author":"Ignatova","year":"2002","journal-title":"Glia"},{"key":"key20180107223334_b10-or-30-04-1645","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.advenzreg.2010.09.017","article-title":"Deciphering the signaling pathways of cancer stem cells of glioblastoma multiforme: role of Akt\/mTOR and MAPK pathways","volume":"51","author":"Jhanwar-Uniyal","year":"2011","journal-title":"Adv Enzyme Regul"},{"key":"key20180107223334_b11-or-30-04-1645","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.cell.2007.06.009","article-title":"AKT\/PKB signaling: navigating downstream","volume":"129","author":"Manning","year":"2007","journal-title":"Cell"},{"key":"key20180107223334_b12-or-30-04-1645","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jbior.2012.10.001","article-title":"Deconstructing mTOR complexes in regulation of glioblastoma multiforme and its stem cells","volume":"53","author":"Jhanwar-Uniyal","year":"2013","journal-title":"Adv Biol Regul"},{"key":"key20180107223334_b13-or-30-04-1645","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/j.ceb.2005.09.009","article-title":"Growing roles for the mTOR pathway","volume":"17","author":"Sarbassov","year":"2005","journal-title":"Curr Opin Cell Biol"},{"key":"key20180107223334_b14-or-30-04-1645","doi-asserted-by":"crossref","first-page":"19384","DOI":"10.1073\/pnas.0810584105","article-title":"mTORC1-dependent and -independent regulation of stem cell renewal, differentiation, and mobilization","volume":"105","author":"Gan","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107223334_b15-or-30-04-1645","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11060-007-9485-1","article-title":"Retinoids induced astrocytic differentiation with down regulation of telomerase activity and enhanced sensitivity to taxol for apoptosis in human glioblastoma T98G and U87MG cells","volume":"87","author":"Das","year":"2008","journal-title":"J Neurooncol"},{"key":"key20180107223334_b16-or-30-04-1645","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s004410100416","article-title":"Embryonic stem cell-derived neurogenesis. Retinoic acid induction and lineage selection of neuronal cells","volume":"305","author":"Guan","year":"2001","journal-title":"Cell Tissue Res"},{"key":"key20180107223334_b17-or-30-04-1645","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s11064-008-9669-x","article-title":"Molecular mechanisms of the combination of retinoid and interferon-gamma for inducing differentiation and increasing apoptosis in human glioblastoma T98G and U87MG cells","volume":"34","author":"Das","year":"2009","journal-title":"Neurochem Res"},{"key":"key20180107223334_b18-or-30-04-1645","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00280-007-0619-0","article-title":"Combination of all-trans retinoic acid and interferon-gamma upregulated p27(kip1) and down regulated CDK2 to cause cell cycle arrest leading to differentiation and apoptosis in human glioblastoma LN18 (pten-proficient) and U87MG (pten-deficient) cells","volume":"62","author":"Zhang","year":"2008","journal-title":"Cancer Chemother Pharmacol"},{"key":"key20180107223334_b19-or-30-04-1645","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s00262-006-0219-6","article-title":"Induction of apoptosis and immune response by all-trans retinoic acid plus interferon-gamma in human malignant glioblastoma T98G and U87MG cells","volume":"56","author":"Haque","year":"2007","journal-title":"Cancer Immunol Immunother"},{"key":"key20180107223334_b20-or-30-04-1645","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1023\/A:1005701507111","article-title":"All-trans retinoic acid in relapsing malignant gliomas: clinical and radiological stabilization associated with the appearance of intratumoral calcifications","volume":"34","author":"Defer","year":"1997","journal-title":"J Neurooncol"},{"key":"key20180107223334_b21-or-30-04-1645","doi-asserted-by":"crossref","first-page":"e1000832","DOI":"10.1371\/journal.pgen.1000832","article-title":"U87MG decoded: the genomic sequence of a cytogenetically aberrant human cancer cell line","volume":"6","author":"Clark","year":"2010","journal-title":"PLoS Genet"},{"key":"key20180107223334_b22-or-30-04-1645","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/BF00697180","article-title":"Characterization of an established human malignant glioma cell line: LN-18","volume":"53","author":"Diserens","year":"1981","journal-title":"Acta Neuropathol"},{"key":"key20180107223334_b23-or-30-04-1645","doi-asserted-by":"crossref","first-page":"6970","DOI":"10.1158\/1078-0432.CCR-07-1229","article-title":"Stem cell marker nestin and c-jun NH2-terminal kinases in tumor and peritumor areas of glioblastoma multiforme: possible prognostic implications","volume":"13","author":"Mangiola","year":"2007","journal-title":"Clin Cancer Res"},{"key":"key20180107223334_b24-or-30-04-1645","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/0092-8674(90)90662-X","article-title":"CNS stem cells express a new class of intermediate filament protein","volume":"60","author":"Lendahl","year":"1990","journal-title":"Cell"},{"key":"key20180107223334_b25-or-30-04-1645","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.phrs.2012.04.005","article-title":"ERK1\/2 MAP kinases: structure, function, and regulation","volume":"66","author":"Roskoski","year":"2012","journal-title":"Pharmacol Res"},{"key":"key20180107223334_b26-or-30-04-1645","first-page":"255","article-title":"Inhibition of mTOR activates the MAPK pathway in glioblastoma multiforme","volume":"6","author":"Albert","year":"2009","journal-title":"Cancer Genomics Proteomics"},{"key":"key20180107223334_b27-or-30-04-1645","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1002\/stem.521","article-title":"Crosstalk between the PI3K\/mTOR and MEK\/ERK pathways involved in the maintenance of self-renewal and tumorigenicity of glioblastoma stem-like cells","volume":"28","author":"Sunayama","year":"2010","journal-title":"Stem Cells"},{"key":"key20180107223334_b28-or-30-04-1645","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.neulet.2009.06.020","article-title":"Erk1\/2 promotes proliferation and inhibits neuronal differentiation of neural stem cells","volume":"461","author":"Wang","year":"2009","journal-title":"Neurosci Lett"},{"key":"key20180107223334_b29-or-30-04-1645","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1002\/stem.753","article-title":"MEK-ERK signaling dictates DNA-repair gene MGMT expression and temozolomide resistance of stem-like glioblastoma cells via the MDM2-p53 axis","volume":"29","author":"Sato","year":"2011","journal-title":"Stem Cells"},{"key":"key20180107223334_b30-or-30-04-1645","first-page":"731","article-title":"Involvement of mTORC1 and mTORC2 in regulation of glioblastoma multiforme growth and motility","volume":"35","author":"Gulati","year":"2009","journal-title":"Int J Oncol"},{"key":"key20180107223334_b31-or-30-04-1645","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1158\/1078-0432.CCR-11-2381","article-title":"The clinical effect of the dual-targeting strategy involving PI3K\/AKT\/mTOR and RAS\/MEK\/ERK pathways in patients with advanced cancer","volume":"18","author":"Shimizu","year":"2012","journal-title":"Clin Cancer Res"},{"key":"key20180107223334_b32-or-30-04-1645","doi-asserted-by":"crossref","first-page":"5294","DOI":"10.1200\/JCO.2005.23.622","article-title":"Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: a north central cancer treatment group study","volume":"23","author":"Galanis","year":"2005","journal-title":"J Clin Oncol"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2013.2625\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T17:42:42Z","timestamp":1515346962000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2013.2625"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,18]]},"references-count":32,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2013,7,18]]},"published-print":{"date-parts":[[2013,10]]}},"alternative-id":["10.3892\/or.2013.2625"],"URL":"https:\/\/doi.org\/10.3892\/or.2013.2625","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,18]]}}}